TrialClinical interventions in aging2013

Tolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥ 65 years) with inadequately controlled type 2 diabetes mellitus.

Chetan S Karyekar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.